PDCD1 and neoplasm: Strikingly, the dominant clone present within the progressing abdominal wall tumor during PD-1 inhibitor therapy was not only present over time but was the most hyperexpanded clone within the treatment-naive lung tumor sampled 7 years earlier (Fig. 4e).